BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38348418)

  • 21. Association Between Parafibromin Expression and Presence of Brown Tumors and Jaw Tumors in Patients with Primary Hyperparathyroidism: Series of Cases with Review of the Literature.
    Popow M; Kaszczewska M; Góralska M; Kaszczewski P; Skwarek-Szewczyk A; Chudziński W; Jażdżewski K; Kolanowska M; Bogdańska M; Starzyńska-Kubicka A; Gałązka Z
    Am J Case Rep; 2022 Oct; 23():e936135. PubMed ID: 36271606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
    Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family: clinical presentations, pathological characteristics and genetic analysis: a case report.
    Yang D; Zheng J; Tang F; He Q; Huang H; Zhou P
    Diagn Pathol; 2022 Sep; 17(1):71. PubMed ID: 36153594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma.
    Korpi-Hyövälti E; Cranston T; Ryhänen E; Arola J; Aittomäki K; Sane T; Thakker RV; Schalin-Jäntti C
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3044-8. PubMed ID: 24823466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A large extended family with hyperparathyroidism-jaw tumor syndrome due to deletion of the third exon of CDC73: clinical and molecular features.
    Le Collen L; Barraud S; Braconnier A; Coppin L; Zachar D; Boulagnon C; Deguelte S; Souchon PF; Spodenkiewicz M; Poirsier C; Aubert S; Odou MF; Delemer B
    Endocrine; 2021 Sep; 73(3):693-701. PubMed ID: 33999366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
    Iacobone M; Masi G; Barzon L; Porzionato A; Macchi V; Ciarleglio FA; Palù G; De Caro R; Viel G; Favia G
    Langenbecks Arch Surg; 2009 Sep; 394(5):817-25. PubMed ID: 19529956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.
    Garrigues G; Batisse-Lignier M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Kelly A; Gay-Bellile M; Viala S; Bidet Y; Bignon YJ; Cavaillé M
    Mol Genet Genomic Med; 2023 May; 11(5):e2133. PubMed ID: 36639964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
    Newey PJ; Bowl MR; Cranston T; Thakker RV
    Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
    Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
    Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyper Parathyroidisim Jaw Tumor Syndrome: A Rare Condition of Incongruous Features.
    Redwin Dhas MP; Karthiga KS; Tatu JE; Eugenia SJ
    Ethiop J Health Sci; 2017 May; 27(3):309-313. PubMed ID: 29217931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors.
    Siu WK; Law CY; Lam CW; Mak CM; Wong GW; Ho AY; Ho KY; Loo KT; Chiu SC; Chow LT; Tong SF; Chan AY
    Fam Cancer; 2011 Dec; 10(4):695-9. PubMed ID: 21732217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE.
    Grigorie D; Sucaliuc A; Ciuffi S; Franceschelli F; Marini F; Ioachim D; Terzea D; Brandi MLL
    Acta Endocrinol (Buchar); 2019; 15(3):398-403. PubMed ID: 32010362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
    Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
    Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid carcinoma.
    Salcuni AS; Cetani F; Guarnieri V; Nicastro V; Romagnoli E; de Martino D; Scillitani A; Cole DEC
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):877-889. PubMed ID: 30551989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome.
    Sun W; Kuang XL; Liu YP; Tian LF; Yan XX; Xu W
    Sci Rep; 2017 Nov; 7(1):15638. PubMed ID: 29142233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.
    Cascón A; Huarte-Mendicoa CV; Javier Leandro-García L; Letón R; Suela J; Santana A; Costa MB; Comino-Méndez I; Landa I; Sánchez L; Rodríguez-Antona C; Cigudosa JC; Robledo M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):922-9. PubMed ID: 21837707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of parathyroid tumours.
    Thakker RV
    J Intern Med; 2016 Dec; 280(6):574-583. PubMed ID: 27306766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Para This, Fibromin That: The Role of CDC73 in Parathyroid Tumors and Familial Tumor Syndromes.
    Ababneh E; Nosé V
    Surg Pathol Clin; 2023 Mar; 16(1):97-105. PubMed ID: 36739170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
    Cetani F; Marcocci C; Torregrossa L; Pardi E
    Endocr Relat Cancer; 2019 Jul; 26(7):R441-R464. PubMed ID: 31085770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.